- Home
- / Hangzhou Bio-Sincerity Pharma-Tech
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Hangzhou Bio-Sincerity Pharma-Tech financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥40.9
2024-10-29
Market Capitalization
¥4.3 B
2024-10-29
Revenue
¥672.3 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 16, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 81.9M | 156.1M | 206.4M | 373.7M | 604.9M | 1.0B | 791.3M | 672.3M |
| Cost of goods sold | 37.7M | 59.1M | 70.9M | 122.5M | 198.2M | 350.7M | 385.1M | 410.2M |
| Gross profit | 44.1M | 97.0M | 135.5M | 251.2M | 406.7M | 661.0M | 407.0M | 262.7M |
| Gross profit margin, % | 53.9% | 62.1% | 65.7% | 67.2% | 65.3% | 51.4% | 39.1% | |
| Operating expense total | 32.7M | 48.4M | 80.2M | 106.0M | 220.6M | 303.0M | 271.5M | 160.4M |
| Depreciation and amortization | 30.3M | 56.9M | 87.9M | 145.3M | 157.0M | |||
| EBITDA | 10.5M | 48.3M | 54.4M | 144.3M | 185.4M | 358.1M | 135.5M | 102.1M |
| EBITDA margin, % | 12.8% | 30.9% | 26.4% | 30.6% | 35.4% | 17.1% | 15.2% | |
| EBIT | 9.8M | 49.9M | 64.2M | 120.5M | 150.2M | 274.6M | (26.3M) | (61.3M) |
| EBIT margin, % | 11.9% | 31.9% | 31.1% | 24.8% | 27.1% | -3.3% | -9.1% | |
| Interest income | 287.0K | 916.0K | 471.0K | 2.3M | 42.0M | 28.2M | 13.0M | 3.0M |
| Interest expense | 841.0K | 297.0K | 639.0K | 3.7M | 1.3M | 7.0M | 16.9M | 21.0M |
| Pre tax profit | 12.1M | 51.0M | 65.1M | 118.9M | 190.9M | 295.7M | (36.1M) | (91.1M) |
| Income tax expense | 611.0K | 6.0M | 7.9M | 8.0M | (3.1M) | 23.7M | 16.9M | (743.0K) |
| Net Income | 11.5M | 45.0M | 57.2M | 111.0M | 194.0M | 272.0M | (52.9M) | (90.4M) |